Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(EXC, HIRU, PWRM, IEC, SVVS) - Stocks to Watch! from Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

________________________________________

___

Exelon Corporation (NYSE:EXC) Autumn weather has finally arrived, and colder temperatures are just around the corner. So now is the time for PECO customers to prepare for winter.  PECO has a number of programs for low-and fixed-income customers including the Low-Income Home Energy Assistance Programwhich provides grants to help meet monthly heating costs. Program eligibility is based on family size and income, and the application season begins in November.

Based in Philadelphia, PECO is an electric and natural gas utility subsidiary of Exelon Corporation. Exelon Corporation, a utility services holding company, through its subsidiaries, engages in the generation, transmission, distribution, and sale of electricity to residential, commercial, industrial, and wholesale customers in northern Illinois.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

  Hiru Corporation (OTCPK:HIRU)

Currently Hiru Corporation subsidiary Jiangxi Shaungshi Animal Health Products (AHP) Co., along with Shuangshi subsidiary Jiangxi Ian Van Agricultural Development Corporation, signed a reservoir lease with Tang Nan Zhang Zhongxi Village in Nanchang County.

For the agricultural development and to develop into the aquacultural market, Shaungshi AHP and Ian Van Agricultural Development Corporation intend to make use of the leased freshwater reservoir. The location of the reservoir in the area of Poyang Lake, China's largest fresh water lake (3,583 square kilometers), companies in the area appropriate this form of business expansion, as the global demand for aquatic products has been escalating progressively since the 1970's, and China plays a key role in this market as a producer, consumer and exporter.

Hiru Corporation intends to continue its work in the development, production and marketing of both well-established and new veterinary drugs, and nutritional additives (amino acids, vitamins, trace elements, etc.) for the Chinese market.

Hiru Corporation is pleased with this development and looks forward to future growth.

Hiru Corporation operates through its subsidiary, Jiangxi Shaungshi Pharmaceutical Co., Ltd., is a producer of Chinese herbs for the naturopathic industry in China. Jiangxi Shaungshi Pharmaceutical Co., Ltd. focuses on producing and manufacturing of herbs, herbal extracts and herbal preparations. The company's products are based on the traditional Chinese systems. Company researches and develops dosage approaches and health applications of these traditional recipes. On December 3, 2009, HIRU completed the merger with the China-based company Jiangxi Shaungshi Pharmaceutical Co., Ltd.

To learn more about HIRU visit:  http://www.hirucorporation.com

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

IEC Electronics Corp. (AMEX:IEC) recently announced its results for the fourth quarter and fiscal year ending September 30, 2010. For the quarter, the Company reported revenue of $27.3 million and operating income of $2.1 million.

IEC Electronics Corp. provides electronic manufacturing services (NYSE:EMS) to technology companies in the United States.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

  Power3 Medical Products, Inc. (OTC:PWRM)

PWRM recently delivered four poster presentations at the 2010 ICAD. These presentations discussed PWRM’s diagnostic test, NuroPro, and focused on PWRM’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

“In preparation for commercialization, our objective at this meeting was to show how Power3 ’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease,” stated Dr. Ira L. Goldknopf, PWRM ’s President & Chief Scientific Officer. “It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.”

“We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” commented Helen R. Park, MS, CEO of PWRM, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”

“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

PWRM has filed several patent applications that are currently pending for its NuroPro technology. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China. PWRM  has also published 6 articles on NuroPro in peer-reviewed scientific journals. PWRM intends to publish these latest findings as well.

PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM’s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease. PWRM ’s products analyze proteins and their mutations to assess an individual’s risk for developing disease later in life or a patient’s likelihood of responding to a particular drug; assess a patient’s risk of disease progression and disease recurrence; and measure a patient’s exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. PWRM was founded in 1992 and is based in The Woodlands, Texas.

To learn more about PWRM visit: http://www.Power3Medical.com

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Savvis, Inc. (NASDAQ:SVVS), a global leader in cloud infrastructure and hosted IT solutions for enterprises, recently announced that it has reached an agreement with global interdealer broker ICAP to provide Savvis' clients who are also authorized traders of EBS and BrokerTec with ultra-low latency direct access to the EBS foreign exchange and BrokerTec fixed-income trading platforms via ICAP's premium i-Cross colocation service.

Savvis, Inc. is a global leader in cloud infrastructure and hosted IT solutions for enterprises.

___

**********************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Hiru Corporation (OTCPK:HIRU). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

________________________________________

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.